GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tocagen Inc (NAS:TOCA) » Definitions » Net Interest Income

Tocagen (Tocagen) Net Interest Income : $-2.74 Mil (TTM As of Mar. 2020)


View and export this data going back to 2017. Start your Free Trial

What is Tocagen Net Interest Income?

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors. Tocagen's net interest income for the three months ended in Mar. 2020 was $-0.70 Mil. Its net interest income for the trailing twelve months (TTM) ended in Mar. 2020 was $-2.74 Mil.

Tocagen Net Interest Income Historical Data

The historical data trend for Tocagen's Net Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tocagen Net Interest Income Chart

Tocagen Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19
Net Interest Income
-0.21 -1.84 -1.34 -1.40 -2.26

Tocagen Quarterly Data
Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
Net Interest Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.21 -0.30 -1.61 -0.13 -0.70

Tocagen Net Interest Income Calculation

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors.

Net Interest Income for the trailing twelve months (TTM) ended in Mar. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.74 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tocagen Net Interest Income Related Terms

Thank you for viewing the detailed overview of Tocagen's Net Interest Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Tocagen (Tocagen) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tocagen Inc (NAS:TOCA) » Definitions » Net Interest Income
Comparable Companies
TNXP MGEN ETTX PTE ARTH SNBP XYNO BLCM ACER CNBX OCSE:NOVO B ASX:CSL VRTX REGN XKRX:207940 SGEN MRNA ALXN XKRX:068270 INCY
Traded in Other Exchanges
N/A
Address
4242 Campus Point Court, Suite 500, San Diego, CA, USA, 92121
Website
http://www.tocagen.com
Tocagen Inc is a clinical-stage, cancer-selective gene therapy company. It is focused on developing product candidates designed to activate a patient's immune system against their own cancer from within. The company's cancer-selective gene therapy platform is built on retroviral replicating vectors, or RRVs, which are designed to selectively deliver therapeutic genes into the DNA of cancer cells. Tocagen is developing product candidate, Toca 511 and Toca FC, for the treatment of recurrent high grade glioma, or HGG, a brain cancer with limited treatment options, low survival rates and, therefore, a significant unmet medical need. Geographically, the activities are carried out through United States.